Published in Cancer Weekly, June 28th, 1999
The upper age limit for recipients of sibling allogeneic bone marrow transplantation is difficult to define because biologic factors, such as performance status and vital organ function, appear to be more important in determining patient eligibility and selection than chronologic age alone.
As unrelated donor transplants (URD) typically are thought to be associated with an increased risk of transplant-related mortality, even more uncertainty exists as to what age, if any, should constitute a cut-off for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.